CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.

Authors: Shunsuke Hamada, Naohisa Futamura, Kunihiro Ikuta, Hiroshi Urakawa, Eiji Kozawa, Naoki Ishiguro, Yoshihiro Nishida

Source: PLoS ONE, Vol 9, Iss 5, p e96391 (2014)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096391&type=printable; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/785b7d30fe8e496ab54f3466399219a8

Giant cell tumor of bone arising in long bones possibly originates from the metaphyseal region.

Authors: NAOHISA FUTAMURA¹, HIROSHI URAKAWA¹, SATOSHI TSUKUSHI¹, EISUKE ARAI¹, EIJI KOZAWA¹, NAOKI ISHIGURO¹, YOSHIHIRO NISHIDA¹ ynishida@med.nagoya-u.ac.jp

Source: Oncology Letters. Apr2016, Vol. 11 Issue 4, p2629-2634. 6p.

Subject Terms: *GIANT cell tumors, *BONE tumors, *OSTEORADIOGRAPHY, *FEMUR, *GROWTH plate, *ANATOMY

Association of Short Duration From Initial Symptoms to Specialist Consultation With Poor Survival in Soft-Tissue Sarcomas.

Authors: Hiroshi Urakawa, Satoshi Tsukushi, Eisuke Arai, Eiji Kozawa, Naohisa Futamura, Naoki Ishiguro, Yoshihiro Nishida

Source: American Journal of Clinical Oncology; Jun2015, Vol. 38 Issue 3, p266-271, 6p

Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients.

Authors: HIROSHI URAKAWA, SATOSHI TSUKUSHI, HIDESHI SUGIURA, KENJI YAMADA, YOSHIHISA YAMADA, EIJI KOZAWA, EISUKE ARAI, NAOHISA FUTAMURA, NAOKI ISHIGURO, YOSHIHIRO NISHIDA

Source: Oncology Letters; 2014, Vol. 8 Issue 6, p2485-2488, 4p

Subject Terms: BONE cancer treatment, DOXORUBICIN, IFOSFAMIDE, SARCOMA, ADJUVANT treatment of cancer, CANCER treatment, THERAPEUTICS